$1.33 Billion is the total value of 12 West Capital Management LP's 15 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 21.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
GDS | Buy | GDS HLDGS LTDsponsored ads | $411,086,000 | +5.5% | 10,941,879 | +0.2% | 30.93% | -2.7% |
GDDY | GODADDY INCcl a | $194,512,000 | -6.7% | 2,772,801 | 0.0% | 14.63% | -14.0% | |
SHAK | SHAKE SHACK INCcl a | $187,557,000 | +22.1% | 2,597,736 | 0.0% | 14.11% | +12.6% | |
FLT | Sell | FLEETCOR TECHNOLOGIES INC | $90,455,000 | -23.9% | 322,075 | -33.2% | 6.80% | -29.9% |
TECH | BIO TECHNE CORP | $74,267,000 | +5.0% | 356,212 | 0.0% | 5.59% | -3.2% | |
SMAR | Buy | SMARTSHEET INC | $71,279,000 | +28.8% | 1,472,700 | +8.6% | 5.36% | +18.8% |
WORK | New | SLACK TECHNOLOGIES INC | $58,380,000 | – | 1,556,800 | +100.0% | 4.39% | – |
LAUR | LAUREATE EDUCATION INCcl a | $57,659,000 | +4.9% | 3,670,195 | 0.0% | 4.34% | -3.2% | |
RNG | RINGCENTRAL INCcl a | $56,311,000 | +6.6% | 490,000 | 0.0% | 4.24% | -1.7% | |
ALNY | ALNYLAM PHARMACEUTICALS INC | $53,332,000 | -22.4% | 735,000 | 0.0% | 4.01% | -28.4% | |
RGEN | New | REPLIGEN CORP | $44,309,000 | – | 515,524 | +100.0% | 3.33% | – |
ALNY | ALNYLAM PHARMACEUTICALS INCcall | $19,083,000 | -22.4% | 263,000 | 0.0% | 1.44% | -28.4% | |
FNKO | Buy | FUNKO INC | $7,266,000 | +28.7% | 300,000 | +15.4% | 0.55% | +18.7% |
ATRA | ATARA BIOTHERAPEUTICS INC | $3,191,000 | -49.4% | 158,700 | 0.0% | 0.24% | -53.4% | |
DSX | Sell | DIANA SHIPPING INC | $493,000 | -60.3% | 149,047 | -66.1% | 0.04% | -63.4% |
MED | Exit | MEDIFAST INC | $0 | – | -115,341 | -100.0% | -1.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
FLEETCOR TECHNOLOGIES INC | 36 | Q1 2022 | 35.4% |
SHAKE SHACK INC | 35 | Q3 2023 | 16.4% |
DIANA SHIPPING INC | 31 | Q4 2020 | 4.1% |
ALNYLAM PHARMACEUTICALS INC | 26 | Q4 2020 | 11.5% |
GDS HLDGS LTD | 23 | Q3 2023 | 41.1% |
SMARTSHEET INC | 22 | Q3 2023 | 12.6% |
ATARA BIOTHERAPEUTICS INC | 21 | Q3 2020 | 1.6% |
REPLIGEN CORP | 18 | Q3 2023 | 13.5% |
MASONITE INTL CORP NEW | 16 | Q2 2017 | 19.9% |
GODADDY INC | 14 | Q2 2020 | 17.0% |
View 12 West Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
GDS Holdings Ltd | February 14, 2022 | 7,910,578 | 4.4% |
Shake Shack Inc. | February 14, 2022 | 1,791,589 | 4.6% |
Research Solutions, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
Haymaker Acquisition Corp.Sold out | February 14, 2020 | 0 | 0.0% |
LAUREATE EDUCATION, INC.Sold out | February 14, 2020 | 0 | 0.0% |
RYB Education, Inc.Sold out | February 14, 2019 | 0 | 0.0% |
SMARTSHEET INC | February 14, 2019 | 1,084,750 | 3.8% |
ADVANCED DRAINAGE SYSTEMS, INC.Sold out | February 14, 2018 | 0 | 0.0% |
ARI NETWORK SERVICES INC /WISold out | February 14, 2018 | 0 | 0.0% |
ATLANTIC POWER CORPSold out | February 14, 2018 | 0 | 0.0% |
View 12 West Capital Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-28 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
SC 13G/A | 2023-02-13 |
View 12 West Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.